single arm:metformin

2 trials

Sponsors

Shandong Provincial Qianfoshan Hosptial, Sun Yat-Sen University Cancer Center

Conditions

Colorecal cancerType 2 diabetes mellitus

Phase 2

Metformin combined with FOLFIRI+bevacizumab in the second-line treatment of non-diabetic RAS mutant metastatic colorectal cancer: a multi-center, single-arm phase II clinical study

RecruitingChiCTR2000037943

Sun Yat-Sen University Cancer CenterColorecal cancer

Start: 2020-08-01Updated: 2020-11-16

Phase 4

The effects of slc22a1 and atm gene polymorphisms on insulin resistance in type 2 diabetic patients treated with metformin

RecruitingChiCTR1900026423

Shandong Provincial Qianfoshan HosptialType 2 diabetes mellitus

Start: 2019-10-15Updated: 2019-10-14

Related Papers

A phase II clinical trial of metformin combined with FOLFIRI plus bevacizumab as second-line therapy in patients with <i>RAS</i>-mutant metastatic colorectal cancer.

Journal of Clinical Oncology2024-06-012 citations